4D MOLECULAR THERAPEUTICS IN's ticker is FDMT and the CUSIP is 35104E100. A total of 112 filers reported holding 4D MOLECULAR THERAPEUTICS IN in Q3 2023. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vident Advisory, LLC | 10,574 | $134,607 | 0.00% |
| TWO SIGMA ADVISERS, LP | 87,200 | $1,110,056 | 0.00% |
| HRT FINANCIAL LP | 26,017 | $331 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 670,599 | $8,536,725 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 101,863 | $1,296,716 | 0.00% |
| Ameritas Investment Partners, Inc. | 3,929 | $50,016 | 0.00% |
| MetLife Investment Management, LLC | 21,100 | $268,603 | 0.00% |
| Squarepoint Ops LLC | 47,749 | $607,845 | 0.00% |
| M&T BANK CORP | 39,481 | $502,800 | 0.00% |
| AMERICAN INTERNATIONAL GROUP, INC. | 19,562 | $249,024 | 0.00% |
| METROPOLITAN LIFE INSURANCE CO/NY | 2,612 | $33,251 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 331,516 | $4,220,199 | 0.00% |
| SG Americas Securities, LLC | 12,254 | $156 | 0.00% |
| STATE OF WISCONSIN INVESTMENT BOARD | 52,181 | $664,264 | 0.00% |
| MORGAN STANLEY | 1,465,868 | $18,660,500 | 0.00% |
| BlackRock Inc. | 3,123,676 | $39,764,397 | 0.00% |
| Cutler Group LLC / CA | 1,000 | $12 | 0.00% |
| JPMORGAN CHASE & CO | 585,451 | $7,452,792 | 0.00% |
| Mirae Asset Global Investments Co., Ltd. | 18,912 | $240,750 | 0.00% |
| VANGUARD GROUP INC | 1,902,467 | $24,218,405 | 0.00% |
External links
This page lists 4D MOLECULAR THERAPEUTICS IN's shareholders in Q3 2023. To view 4D MOLECULAR THERAPEUTICS IN's shareholder history, click here.